Plus, listen to our last podcasts of the year on rural hospitals and the CHIPS Act.
View in browser
Brookings Brief

December 20, 2025

U.S. President Donald Trump signs an executive order classifying fentanyl as a "weapon of mass destruction," during a ceremony for the presentation of the Mexican Border Defense Medal in the Oval Office of the White House on December 15, 2025 in Washington, DC. (Anna Moneymaker/Getty Images)

Will designating fentanyl as a weapon of mass destruction misfire?

 

This week, the Trump administration designated illicit fentanyl and related chemicals as weapons of mass destruction (WMDs)—a move that signals a major shift in U.S. drug policy that centers militarized supply-side measures over access to treatment.

 

Vanda Felbab-Brown examines its domestic and international implications, including potential military counternarcotics actions abroad and tougher criminal penalties at home. 

Read more
 

Don't miss our last podcast episodes of 2025

 

How healthcare powers rural economies. Tony Pipa speaks with Kentucky Governor Andy Beshear about what he calls “the biggest threat to rural healthcare in my lifetime.” Governor Beshear explains the economic ripple effects of hospital closures—from lost jobs to declining workforce productivity—and warns that new federal policy proposals could force 35 Kentucky hospitals to shut their doors, with nearly 200 rural hospitals already closed across the US since 2005. 

 

Has the CHIPS Act created jobs? New research finds that the CHIPS and Science Act of 2022 has already spurred about 15,000 new semiconductor-related jobs. On the latest episode of the Brookings Podcast on Economic Activity, Mark Muro joins the study’s authors to discuss what the data reveal about early employment impacts and what they mean for future U.S. industrial policy.

 

About Brookings

 

The Brookings Institution is a nonprofit organization based in Washington, D.C. Our mission is to conduct in-depth, nonpartisan research to improve policy and governance at local, national, and global levels. If you were forwarded this email, sign up for the Brookings Brief to stay updated on our latest work.

 
X/Twitter
Facebook
Instagram
LinkedIn
Brookings

The Brookings Institution,1775 Massachusetts Ave NW, Washington, DC 20036

Unsubscribe | Manage newsletter subscriptions 

The conclusions and recommendations of any Brookings publication are solely those of its author(s), and do not reflect the views of the Institution, its management, or its other scholars.